VERAPAMIL HYDROCHLORIDE
- Product NDC
- 71209-104
- 11-digit product format
- 712090104
- Labeler code
- 71209
- Product ID
- 71209-104_d6b80b6c-59f6-4e63-bb8d-a29a77f4a0a1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- verapamil hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Cadila Pharmaceuticals Limited
- Application
- ANDA206173
- Marketing category
- ANDA
- Marketing start
- 2017-05-27
- Substance
- VERAPAMIL HYDROCHLORIDE
- Active strength
- 120 mg/1
- Pharmacologic classes
- Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| V3888OEY5R | VERAPAMIL HYDROCHLORIDE | 152-11-4 | VERAPAMIL HYDROCHLORIDE |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 71209-104-05 | 71209010405 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71209-104-05) | 2021-12-27 | No | No | Historical |
| 71209-104-10 | 71209010410 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (71209-104-10) | 2021-12-27 | No | No | Historical |